SJT Molecular Research Competitors and Similar CompaniesClear all
SJT Molecular Research's competitors and similar companies include MannKind Corporation, Diasome, Zucara Therapeutics and Kadimastem.
 MannKind Corporation MannKind Corporation is a biopharmaceutical company focused on the discovery, development and commercialization of therapeutic products for patients. |  Diasome Diasome Pharmaceuticals, Inc. is focused on the clinical and commercial development of breakthrough therapies for diabetes and obesity. |  Zucara Therapeutics Zucara Therapeutics is a company developing drug therapies to prevent hypoglycemia in people with diabetes. |  Kadimastem Kadimastem is a biopharmaceutical company that develops industrial regenerative medicine therapies based on differentiated cells derived from human embryonic stem cells (hESCs). | ||
Founding Date | Founding Date 2011 | Founding Date 1991 | Founding Date 2004 | Founding Date 2015 | Founding Date 2009 |
Type | Type Private | Type Public | Type Private | Type Private | Type Public |
Tags | |||||
Locations | Locations Gasteiz, ES HQ | Locations Westlake Village, US HQ Danbury, US | Locations Cleveland, US HQ | Locations Toronto, CA HQ | Locations Ness Ziona, IL HQ |
Employees | Employees 2 | Employees 39513% increase | Employees 1515% increase | Employees 11 | Employees 11 |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) $349m (FY, 2025) | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) N/A |
Cost of goods | Cost of goods N/A | Cost of goods $26.8m (FY, 2025) | Cost of goods N/A | Cost of goods N/A | Cost of goods N/A |
Gross profit | Gross profit N/A | Gross profit $322.2m (FY, 2025) | Gross profit N/A | Gross profit N/A | Gross profit N/A |
Net income | Net income N/A | Net income $5.9m (FY, 2025) | Net income N/A | Net income N/A | Net income (₪26.6m) (FY, 2024) |
Funding | |||||
Latest funding round | Latest funding round N/A | Latest funding round N/A | Latest funding round $ 30m (almost 9 years ago) | Latest funding round $ 3.9m (about 6 years ago) | Latest funding round N/A |
Total funding raised | Total funding raised N/A | Total funding raised $ 200m | Total funding raised $ 42.9m | Total funding raised $ 24.9m | Total funding raised N/A |
For sources of this data, please see the company profile
View Company Profiles
MannKind Corporation
HQ
Westlake Village, US
Employees
395↑ 13% increase
MannKind Corporation is a biopharmaceutical company focused on the discovery, development and commercialization of therapeutic products for patients.
View companyDiasome
HQ
Cleveland, US
Employees
15↑ 15% increase
Diasome Pharmaceuticals, Inc. is focused on the clinical and commercial development of breakthrough therapies for diabetes and obesity.
View companyZucara Therapeutics
HQ
Toronto, CA
Employees
11
Zucara Therapeutics is a company developing drug therapies to prevent hypoglycemia in people with diabetes.
View companyKadimastem
HQ
Ness Ziona, IL
Employees
11
Kadimastem is a biopharmaceutical company that develops industrial regenerative medicine therapies based on differentiated cells derived from human embryonic stem cells (hESCs).
View company